Carr Molly
Transaction: 07/31/2026
OTHER
Change
0
Price
Not reported
Filing
08/04/2026
Type
OTHER
iBio, Inc.
IBIO • Biotechnology
$1.31
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$136.32M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 7.85Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:15 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.31
Change0.00%
Shares Out104.06M
Market Cap$136.32M
Enterprise Value$82.12M
52W Range0.77 - 3.82
Beta1.31
P/E-4.13
P/S1,363.19
P/B1.59
P/FCF-5.73
EV/Sales821.22
Price$1.31
Change0.00%
Shares Out104.06M
Market Cap$136.32M
Enterprise Value$82.12M
52W Range0.77 - 3.82
Beta1.31
P/E-4.13
P/S1,363.19
P/B1.59
P/FCF-5.73
EV/Sales821.22
EV/EBITDA-3.25
EV/FCF-3.45
Earnings Yield-24.24%
FCF Yield-17.46%
Dividend Yield0.00%
Gross Margin-9.30%
Oper. Margin-301.38%
Profit Margin-330.44%
Debt/Eq0.03
Current Ratio7.85
Quick Ratio7.85
Target$5.00
Target Upside281.68%
Target Median$5.00
Target Range5.00 - 5.00
Volume353.52K
Avg Volume896.43K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 7.85Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
88/100
Bullish
Bullish
3
Hold
1
Bearish
0
Price Target
2026-09-04
Low
$5.00
Mean
$5.00
Median
$5.00
High
$5.00
Insider Transactions
Recent executive and insider activity
Carr Molly
Transaction: 07/31/2026
BUY
Change
+430,000
Price
$1.40
Filing
08/04/2026
Type
BUY
Stoner Elizabeth
Transaction: 05/18/2026
BUY
Change
+60,000
Price
$1.42
Filing
05/19/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Carr Molly | OTHER | 0 | Not reported | 07/31/2026 | 08/04/2026 |
| Carr Molly | BUY | +430,000 | $1.40 | 07/31/2026 | 08/04/2026 |
| Stoner Elizabeth | BUY | +60,000 | $1.42 | 05/18/2026 | 05/19/2026 |
| Stoner Elizabeth | OTHER | 0 | Not reported | 05/07/2026 | 05/15/2026 |
| Banjak Marc | BUY | +12,500 | $1.64 | 03/26/2026 | 03/27/2026 |
| Brenner Martin | BUY | +12,336 | $2.02 | 03/19/2026 | 03/23/2026 |
| Duran Felipe | BUY | +24,835 | $2.02 | 03/19/2026 | 03/23/2026 |
| Brenner Martin | BUY | +479,000 | $2.23 | 01/28/2026 | 01/30/2026 |
| Duran Felipe | BUY | +179,000 | $2.23 | 01/28/2026 | 01/30/2026 |
| Banjak Marc | BUY | +146,000 | $2.23 | 01/28/2026 | 01/30/2026 |
| Arkowitz David | BUY | +13,500 | $1.00 | 11/20/2025 | 11/24/2025 |
| Parada Antonio Bernardino Guimaraes | BUY | +13,500 | $1.00 | 11/20/2025 | 11/24/2025 |
| Kropotova Alexandra | BUY | +13,500 | $1.00 | 11/20/2025 | 11/24/2025 |
| Sender Gary | BUY | +13,500 | $1.00 | 11/20/2025 | 11/24/2025 |
| Clark William D | BUY | +13,500 | $1.00 | 11/20/2025 | 11/24/2025 |
| Schimmelpennink Evert B. | BUY | +13,500 | $1.00 | 11/20/2025 | 11/24/2025 |
| Brenner Martin | BUY | +180,000 | $0.89 | 10/20/2025 | 10/22/2025 |
| Banjak Marc | BUY | +55,000 | $0.89 | 10/20/2025 | 10/22/2025 |
| Duran Felipe | BUY | +75,000 | $0.89 | 10/20/2025 | 10/22/2025 |
| Brenner Martin | BUY | +230,700 | $3.48 | 02/21/2025 | 02/24/2025 |